1. Home
  2. Search results

Search results

Désélectionner les catégories

Validation of Three MicroScan Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings.

Publications
Published on
Journal Reference: Diagnostics (Basel, Switzerland) 2022 Aug 30; 12(9); . doi: 10.3390/diagnostics12092106. Epub 2022 08 30

Anthropometric deficits and the associated risk of death by age and sex in children aged 6-59 months: A meta-analysis.

Publications
Published on
Journal Reference: Maternal & child nutrition 2022 Sep 27; . doi: 10.1111/mcn.13431. Epub 2022 09 27

TB screening, prevention and treatment cascade in a Malawi prison.

Publications
Published on
Journal Reference: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2022 Oct 01; 26(10); . doi: 10.5588/ijtld.22.0115. Epub 2022 09 28

Epi'Climate Action: Epicentre's environmental action

Editorial page
Published on 05.10.2022
Reducing our environmental impact is now part of Epicentre's mission. At the end of 2021, Epicentre has committed itself to a decarbonization process.

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines.

Publications
Published on
Journal Reference: BMJ open 2022 Oct 05; 12(10); . doi: 10.1136/bmjopen-2022-061673. Epub 2022 10 05

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.

Publications
Published on
Journal Reference: Vaccine 2022 Oct 05; . doi: 10.1016/j.vaccine.2022.09.037. Epub 2022 10 05

Céline Langendorf

Profile
Published on 13.10.2022

Patrick Barks

Profile
Published on 18.10.2022
R package development and data pipelines for clinical studies and outbreak monitoring

Typhoid fever: mass vaccination effective among children under 15 in Zimbabwe

News
Published on 18.10.2022
A real-world study in Zimbabwe confirms the effectiveness of mass vaccination against typhoid fever in individuals under the age of 15.

Maria Lightowler

Profile
Published on 18.10.2022